Robert Wieder

Rbhs-New Jersey Medical School

$3,730,696

Attributed

$3,730,696

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $806K · FY2009–15

$1M$750K$500K$250K$0

'09

'10

'11

'12

'13

'14

'15

Funding mix

By agency

NIH$3,730,696 · 2

By mechanism

U10$3,353,176 · 1

R21$377,520 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsMedicineInner CityMalignant Neoplasm Of Cervix UteriDentistryMedical SchoolsIncidenceClinical TrialsLow IncomeCommunity Clinical Oncology ProgramCountyBreastEducational AspectsEnsureCollaborationsClinical ResearchCancer CenterCancer ControlBaseLatinoAfrican AmericanCommunitiesBrain NeoplasmsMinority